References
- Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404. https://doi.org/10.1016/S1474-4422(15)00401-9 PMid:26906964
- Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: Causes, management, and predictors of outcome. Neurology. 2015;84:359-66. https://doi.org/10.1212/WNL.0000000000001190 PMid:25540320
- Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54(7):899-904. https://doi.org/10.1093/cid/cir1038 PMid:22281844
- Lancaster E. Paraneoplastic disorders. Continuum (Minneap Minn). 2017;23(6):1653-79. https://doi.org/10.1212/CON.0000000000000542 PMid:29200116
- Abboud H, Rossman I, Mealy MA, Hill E, Thompson N, Banerjee A, et al. Neuronal autoantibodies: Differentiating clinically relevant and clinically irrelevant results. J Neurol. 2017;264(11):2284-92. https://doi.org/10.1007/s00415-017-8627-4 PMid:28975404
- Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol. 2013;12(2):157-65. https://doi.org/10.1016/S1474-4422(12)70310-1 PMid:23290630
- Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: New developments and future challenges. Lancet Neurol. 2011;10(8):759-72. https://doi.org/10.1016/S1474-4422(11)70096-5 PMid:21777830
- Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411-28. https://doi.org/10.1002/ana.24117 PMid:24700511
- Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017;140(9):2415-25. https://doi.org/10.1093/brain/awx200 PMid:29050399
- Kumar N, Abboud H. Iatrogenic CNS demyelination in the era of modern biologics. Mult Scler. 2019;25(8):1079-85. https://doi.org/10.1177/1352458519828601 PMid:30767720
- Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Chiriboga SA, et al. Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy. Ann Neurol. 2020;87(2):313-23. https://doi.org/10.1002/ana.25655 PMid:31782181
- Nguyen MK, Rastogi A, Kurtz I. True hyponatremia secondary to intravenous immunoglobulin. Clin Exp Nephrol. 2006;10(2):124-6. https://doi.org/10.1007/s10157-006-0416-9 PMid:16791398
- Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler. 2016;22(2):185-92. https://doi.org/10.1177/1352458515581438 PMid:25921047
- DeSena AD, Noland DK, Matevosyan K, King K, Phillips L, Qureshi SS, et al. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review. J Clin Apher. 2015;30(4):212-16. https://doi.org/10.1002/jca.21363 PMid:25664728
- Höftberger R, Titulaer MJ, Sabater L, Dome B, Rózsás A, Hegedus B, et al. Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients. Neurol. 2013;81(17):1500-6. https://doi.org/10.1212/WNL.0b013e3182a9585f PMid:24068784